Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption
Clinical trial NCT03551249 · COMPLETED
Trial details
- NCT number
- NCT03551249
- Sponsor
- InSightec
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-26
- Primary completion
- 2023-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.